0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-21T363
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Intermediates Market Research Report 2020
BUY CHAPTERS

Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-21T363
Report
September 2022
125 Pages
QYResearch
Region: Global, North America, China, Europe, France, Germany, Italy, Japan, Australia, Taiwan, Philippines, Malaysia, India, Indonesia, South Korea, Saudi Arabia, Turkey, Thailand
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Pharmaceutical Intermediates market is projected to reach US$ 280690 million by 2028 from an estimated US$ 194550 million in 2022, at a CAGR of 6.3% during 2023 and 2028.

Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Intermediates.
The Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Product Type Insights
Global markets are presented by Pharmaceutical Intermediates type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Pharmaceutical Intermediates are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Pharmaceutical Intermediates Segment by Type

GMP
Non-GMP
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pharmaceutical Intermediates market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pharmaceutical Intermediates market.

Pharmaceutical Intermediates Segment by Application

Antibiotics
Antipyretic Analgesics
Vitamins
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pharmaceutical Intermediates market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pharmaceutical Intermediates industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Intermediates

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market by Type
1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market by Application
1.3.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
2.1.1 Global Pharmaceutical Intermediates Revenue 2017-2028
2.1.2 Global Pharmaceutical Intermediates Sales 2017-2028
2.2 Pharmaceutical Intermediates Market Size by Region: 2022 Versus 2028
2.3 Pharmaceutical Intermediates Sales by Region (2017-2028)
2.3.1 Global Pharmaceutical Intermediates Sales by Region: 2017-2022
2.3.2 Global Pharmaceutical Intermediates Sales Forecast by Region (2023-2028)
2.3.3 Global Pharmaceutical Intermediates Sales Market Share by Region (2017-2028)
2.4 Pharmaceutical Intermediates Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Pharmaceutical Intermediates Revenue by Region: 2017-2022
2.4.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2023-2028)
2.4.3 Global Pharmaceutical Intermediates Revenue Market Share by Region (2017-2028)
3 Global Pharmaceutical Intermediates by Manufacturers
3.1 Global Top Pharmaceutical Intermediates Manufacturers by Sales
3.1.1 Global Pharmaceutical Intermediates Sales by Manufacturer (2017-2022)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Pharmaceutical Intermediates Manufacturers by Revenue
3.2.1 Global Pharmaceutical Intermediates Revenue by Manufacturer (2017-2022)
3.2.2 Global Pharmaceutical Intermediates Revenue Share by Manufacturer (2017-2022)
3.3 Global Pharmaceutical Intermediates Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue
3.4.2 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Pharmaceutical Intermediates Manufacturing Base Distribution, Product Type
3.5.1 Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Pharmaceutical Intermediates Product Type
3.5.3 Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Lonza
4.1.1 Lonza Corporation Information
4.1.2 Lonza Description, Business Overview
4.1.3 Lonza Pharmaceutical Intermediates Products Offered
4.1.4 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Lonza Pharmaceutical Intermediates Sales by Product in 2021
4.1.6 Lonza Pharmaceutical Intermediates Sales by Application in 2021
4.1.7 Lonza Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.1.8 Lonza Recent Developments
4.2 Catalent
4.2.1 Catalent Corporation Information
4.2.2 Catalent Description, Business Overview
4.2.3 Catalent Pharmaceutical Intermediates Products Offered
4.2.4 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Catalent Pharmaceutical Intermediates Sales by Product in 2021
4.2.6 Catalent Pharmaceutical Intermediates Sales by Application in 2021
4.2.7 Catalent Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.2.8 Catalent Recent Developments
4.3 Patheon
4.3.1 Patheon Corporation Information
4.3.2 Patheon Description, Business Overview
4.3.3 Patheon Pharmaceutical Intermediates Products Offered
4.3.4 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Patheon Pharmaceutical Intermediates Sales by Product in 2021
4.3.6 Patheon Pharmaceutical Intermediates Sales by Application in 2021
4.3.7 Patheon Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.3.8 Patheon Recent Developments
4.4 Jubilant
4.4.1 Jubilant Corporation Information
4.4.2 Jubilant Description, Business Overview
4.4.3 Jubilant Pharmaceutical Intermediates Products Offered
4.4.4 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Jubilant Pharmaceutical Intermediates Sales by Product in 2021
4.4.6 Jubilant Pharmaceutical Intermediates Sales by Application in 2021
4.4.7 Jubilant Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.4.8 Jubilant Recent Developments
4.5 Granules
4.5.1 Granules Corporation Information
4.5.2 Granules Description, Business Overview
4.5.3 Granules Pharmaceutical Intermediates Products Offered
4.5.4 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Granules Pharmaceutical Intermediates Sales by Product in 2021
4.5.6 Granules Pharmaceutical Intermediates Sales by Application in 2021
4.5.7 Granules Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.5.8 Granules Recent Developments
4.6 Ganesh
4.6.1 Ganesh Corporation Information
4.6.2 Ganesh Description, Business Overview
4.6.3 Ganesh Pharmaceutical Intermediates Products Offered
4.6.4 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Ganesh Pharmaceutical Intermediates Sales by Product in 2021
4.6.6 Ganesh Pharmaceutical Intermediates Sales by Application in 2021
4.6.7 Ganesh Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.6.8 Ganesh Recent Development
4.7 Chemcon
4.7.1 Chemcon Corporation Information
4.7.2 Chemcon Description, Business Overview
4.7.3 Chemcon Pharmaceutical Intermediates Products Offered
4.7.4 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Chemcon Pharmaceutical Intermediates Sales by Product in 2021
4.7.6 Chemcon Pharmaceutical Intermediates Sales by Application in 2021
4.7.7 Chemcon Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.7.8 Chemcon Recent Development
4.8 BASF
4.8.1 BASF Corporation Information
4.8.2 BASF Description, Business Overview
4.8.3 BASF Pharmaceutical Intermediates Products Offered
4.8.4 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.8.5 BASF Pharmaceutical Intermediates Sales by Product in 2021
4.8.6 BASF Pharmaceutical Intermediates Sales by Application in 2021
4.8.7 BASF Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.8.8 BASF Recent Development
4.9 Porton
4.9.1 Porton Corporation Information
4.9.2 Porton Description, Business Overview
4.9.3 Porton Pharmaceutical Intermediates Products Offered
4.9.4 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Porton Pharmaceutical Intermediates Sales by Product in 2021
4.9.6 Porton Pharmaceutical Intermediates Sales by Application in 2021
4.9.7 Porton Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.9.8 Porton Recent Development
4.10 Lianhetech
4.10.1 Lianhetech Corporation Information
4.10.2 Lianhetech Description, Business Overview
4.10.3 Lianhetech Pharmaceutical Intermediates Products Offered
4.10.4 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Lianhetech Pharmaceutical Intermediates Sales by Product in 2021
4.10.6 Lianhetech Pharmaceutical Intermediates Sales by Application in 2021
4.10.7 Lianhetech Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.10.8 Lianhetech Recent Development
4.11 ABA Chem
4.11.1 ABA Chem Corporation Information
4.11.2 ABA Chem Description, Business Overview
4.11.3 ABA Chem Pharmaceutical Intermediates Products Offered
4.11.4 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.11.5 ABA Chem Pharmaceutical Intermediates Sales by Product in 2021
4.11.6 ABA Chem Pharmaceutical Intermediates Sales by Application in 2021
4.11.7 ABA Chem Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.11.8 ABA Chem Recent Development
4.12 Tianma
4.12.1 Tianma Corporation Information
4.12.2 Tianma Description, Business Overview
4.12.3 Tianma Pharmaceutical Intermediates Products Offered
4.12.4 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Tianma Pharmaceutical Intermediates Sales by Product in 2021
4.12.6 Tianma Pharmaceutical Intermediates Sales by Application in 2021
4.12.7 Tianma Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.12.8 Tianma Recent Development
4.13 Jiujiujiu
4.13.1 Jiujiujiu Corporation Information
4.13.2 Jiujiujiu Description, Business Overview
4.13.3 Jiujiujiu Pharmaceutical Intermediates Products Offered
4.13.4 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Jiujiujiu Pharmaceutical Intermediates Sales by Product in 2021
4.13.6 Jiujiujiu Pharmaceutical Intermediates Sales by Application in 2021
4.13.7 Jiujiujiu Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.13.8 Jiujiujiu Recent Development
4.14 Alpha
4.14.1 Alpha Corporation Information
4.14.2 Alpha Description, Business Overview
4.14.3 Alpha Pharmaceutical Intermediates Products Offered
4.14.4 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Alpha Pharmaceutical Intermediates Sales by Product in 2021
4.14.6 Alpha Pharmaceutical Intermediates Sales by Application in 2021
4.14.7 Alpha Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.14.8 Alpha Recent Development
4.15 Jiuzhou
4.15.1 Jiuzhou Corporation Information
4.15.2 Jiuzhou Description, Business Overview
4.15.3 Jiuzhou Pharmaceutical Intermediates Products Offered
4.15.4 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Jiuzhou Pharmaceutical Intermediates Sales by Product in 2021
4.15.6 Jiuzhou Pharmaceutical Intermediates Sales by Application in 2021
4.15.7 Jiuzhou Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.15.8 Jiuzhou Recent Development
4.16 Yongtai
4.16.1 Yongtai Corporation Information
4.16.2 Yongtai Description, Business Overview
4.16.3 Yongtai Pharmaceutical Intermediates Products Offered
4.16.4 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Yongtai Pharmaceutical Intermediates Sales by Product in 2021
4.16.6 Yongtai Pharmaceutical Intermediates Sales by Application in 2021
4.16.7 Yongtai Pharmaceutical Intermediates Sales by Geographic Area in 2021
4.16.8 Yongtai Recent Development
5 Breakdown Data by Type
5.1 Global Pharmaceutical Intermediates Sales by Type (2017-2028)
5.1.1 Global Pharmaceutical Intermediates Sales by Type (2017-2022)
5.1.2 Global Pharmaceutical Intermediates Sales Forecast by Type (2023-2028)
5.1.3 Global Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
5.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2017-2028)
5.2.1 Global Pharmaceutical Intermediates Revenue by Type (2017-2022)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2023-2028)
5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
5.3 Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Pharmaceutical Intermediates Sales by Application (2017-2028)
6.1.1 Global Pharmaceutical Intermediates Sales by Application (2017-2022)
6.1.2 Global Pharmaceutical Intermediates Sales Forecast by Application (2023-2028)
6.1.3 Global Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
6.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2017-2028)
6.2.1 Global Pharmaceutical Intermediates Revenue by Application (2017-2022)
6.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2023-2028)
6.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
6.3 Pharmaceutical Intermediates Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Pharmaceutical Intermediates Market Size YoY Growth 2017-2028
7.2 North America Pharmaceutical Intermediates Market Facts & Figures by Country
7.2.1 North America Pharmaceutical Intermediates Sales by Country (2017-2028)
7.2.2 North America Pharmaceutical Intermediates Revenue by Country (2017-2028)
7.3 North America Pharmaceutical Intermediates Sales by Type
7.4 North America Pharmaceutical Intermediates Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Intermediates Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Pharmaceutical Intermediates Market Facts & Figures by Region
8.2.1 Asia-Pacific Pharmaceutical Intermediates Sales by Region (2017-2028)
8.2.2 Asia-Pacific Pharmaceutical Intermediates Revenue by Region (2017-2028)
8.3 Asia-Pacific Pharmaceutical Intermediates Sales by Type
8.4 Asia-Pacific Pharmaceutical Intermediates Sales by Application
9 Europe
9.1 Europe Pharmaceutical Intermediates Market Size YoY Growth 2017-2028
9.2 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
9.2.1 Europe Pharmaceutical Intermediates Sales by Country (2017-2028)
9.2.2 Europe Pharmaceutical Intermediates Revenue by Country (2017-2028)
9.3 Europe Pharmaceutical Intermediates Sales by Type
9.4 Europe Pharmaceutical Intermediates Sales by Application
10 Latin America
10.1 Latin America Pharmaceutical Intermediates Market Size YoY Growth 2017-2028
10.2 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
10.2.1 Latin America Pharmaceutical Intermediates Sales by Country (2017-2028)
10.2.2 Latin America Pharmaceutical Intermediates Revenue by Country (2017-2028)
10.3 Latin America Pharmaceutical Intermediates Sales by Type
10.4 Latin America Pharmaceutical Intermediates Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Pharmaceutical Intermediates Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
11.2.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2017-2028)
11.2.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2017-2028)
11.3 Middle East and Africa Pharmaceutical Intermediates Sales by Type
11.4 Middle East and Africa Pharmaceutical Intermediates Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Pharmaceutical Intermediates Supply Chain Analysis
12.2 Pharmaceutical Intermediates Key Raw Materials and Upstream Suppliers
12.3 Pharmaceutical Intermediates Clients Analysis
12.4 Pharmaceutical Intermediates Sales Channel and Sales Model Analysis
12.4.1 Pharmaceutical Intermediates Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Pharmaceutical Intermediates Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Pharmaceutical Intermediates Distributors
13 Market Dynamics
13.1 Pharmaceutical Intermediates Industry Trends
13.2 Pharmaceutical Intermediates Market Drivers
13.3 Pharmaceutical Intermediates Market Challenges
13.4 Pharmaceutical Intermediates Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Pharmaceutical Intermediates Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of GMP
    Table 3. Major Manufacturers of Non-GMP
    Table 4. Global Pharmaceutical Intermediates Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Pharmaceutical Intermediates Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 6. Global Pharmaceutical Intermediates Sales by Region (2017-2022) & (K MT)
    Table 7. Global Pharmaceutical Intermediates Sales Forecast by Region (2023-2028) & (K MT)
    Table 8. Global Pharmaceutical Intermediates Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global Pharmaceutical Intermediates Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 10. Global Pharmaceutical Intermediates Sales by Manufacturer (2017-2022) & (K MT)
    Table 11. Global Pharmaceutical Intermediates Sales Share by Manufacturer (2017-2022)
    Table 12. Pharmaceutical Intermediates Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 13. Pharmaceutical Intermediates Revenue Share by Manufacturer (2017-2022)
    Table 14. Key Manufacturers Pharmaceutical Intermediates Price (2017-2022) & (USD/MT)
    Table 15. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2021
    Table 16. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 17. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2021)
    Table 18. Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Pharmaceutical Intermediates Product Type
    Table 20. Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Lonza Corporation Information
    Table 23. Lonza Description and Business Overview
    Table 24. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 25. Lonza Pharmaceutical Intermediates Product
    Table 26. Lonza Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 27. Lonza Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 28. Lonza Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 29. Lonza Recent Development
    Table 30. Catalent Corporation Information
    Table 31. Catalent Description and Business Overview
    Table 32. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 33. Catalent Pharmaceutical Intermediates Product
    Table 34. Catalent Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 35. Catalent Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 36. Catalent Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 37. Catalent Recent Development
    Table 38. Patheon Corporation Information
    Table 39. Patheon Description and Business Overview
    Table 40. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 41. Patheon Pharmaceutical Intermediates Product
    Table 42. Patheon Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 43. Patheon Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 44. Patheon Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 45. Patheon Recent Development
    Table 46. Jubilant Corporation Information
    Table 47. Jubilant Description and Business Overview
    Table 48. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 49. Jubilant Pharmaceutical Intermediates Product
    Table 50. Jubilant Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 51. Jubilant Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 52. Jubilant Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 53. Jubilant Recent Development
    Table 54. Granules Corporation Information
    Table 55. Granules Description and Business Overview
    Table 56. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 57. Granules Pharmaceutical Intermediates Product
    Table 58. Granules Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 59. Granules Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 60. Granules Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 61. Granules Recent Development
    Table 62. Ganesh Corporation Information
    Table 63. Ganesh Description and Business Overview
    Table 64. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Ganesh Pharmaceutical Intermediates Product
    Table 66. Ganesh Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 67. Ganesh Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 68. Ganesh Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 69. Chemcon Corporation Information
    Table 70. Chemcon Description and Business Overview
    Table 71. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 72. Chemcon Pharmaceutical Intermediates Product
    Table 73. Chemcon Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 74. Chemcon Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 75. Chemcon Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 76. BASF Corporation Information
    Table 77. BASF Description and Business Overview
    Table 78. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 79. BASF Pharmaceutical Intermediates Product
    Table 80. BASF Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 81. BASF Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 82. BASF Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 83. Porton Corporation Information
    Table 84. Porton Description and Business Overview
    Table 85. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 86. Porton Pharmaceutical Intermediates Product
    Table 87. Porton Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 88. Porton Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 89. Porton Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 90. Lianhetech Corporation Information
    Table 91. Lianhetech Description and Business Overview
    Table 92. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 93. Lianhetech Pharmaceutical Intermediates Product
    Table 94. Lianhetech Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 95. Lianhetech Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 96. Lianhetech Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 97. ABA Chem Corporation Information
    Table 98. ABA Chem Description and Business Overview
    Table 99. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. ABA Chem Pharmaceutical Intermediates Product
    Table 101. ABA Chem Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 102. ABA Chem Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 103. ABA Chem Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 104. Tianma Corporation Information
    Table 105. Tianma Description and Business Overview
    Table 106. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 107. Tianma Pharmaceutical Intermediates Product
    Table 108. Tianma Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 109. Tianma Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 110. Tianma Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 111. Jiujiujiu Corporation Information
    Table 112. Jiujiujiu Description and Business Overview
    Table 113. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 114. Jiujiujiu Pharmaceutical Intermediates Product
    Table 115. Jiujiujiu Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 116. Jiujiujiu Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 117. Jiujiujiu Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 118. Alpha Corporation Information
    Table 119. Alpha Description and Business Overview
    Table 120. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 121. Alpha Pharmaceutical Intermediates Product
    Table 122. Alpha Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 123. Alpha Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 124. Alpha Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 125. Jiuzhou Corporation Information
    Table 126. Jiuzhou Description and Business Overview
    Table 127. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Jiuzhou Pharmaceutical Intermediates Product
    Table 129. Jiuzhou Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 130. Jiuzhou Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 131. Jiuzhou Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 132. Yongtai Corporation Information
    Table 133. Yongtai Description and Business Overview
    Table 134. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Yongtai Pharmaceutical Intermediates Product
    Table 136. Yongtai Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Product in 2021
    Table 137. Yongtai Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Application in 2021
    Table 138. Yongtai Pharmaceutical Intermediates Sales Proportion of Pharmaceutical Intermediates by Geographic Area in 2021
    Table 139. Global Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
    Table 140. Global Pharmaceutical Intermediates Sales Forecast by Type (2023-2028) & (K MT)
    Table 141. Global Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
    Table 142. Global Pharmaceutical Intermediates Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 143. Global Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
    Table 144. Global Pharmaceutical Intermediates Sales Forecast by Application (2023-2028) & (K MT)
    Table 145. Global Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
    Table 146. Global Pharmaceutical Intermediates Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 147. North America Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
    Table 148. North America Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
    Table 149. North America Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
    Table 150. North America Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
    Table 151. North America Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
    Table 152. North America Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
    Table 153. Asia-Pacific Pharmaceutical Intermediates Sales by Region (2017-2022) & (K MT)
    Table 154. Asia-Pacific Pharmaceutical Intermediates Sales by Region (2023-2028) & (K MT)
    Table 155. Asia-Pacific Pharmaceutical Intermediates Revenue by Region (2017-2028) & (US$ Million)
    Table 156. Asia-Pacific Pharmaceutical Intermediates Revenue by Region (2023-2028) & (US$ Million)
    Table 157. Asia-Pacific Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
    Table 158. Asia-Pacific Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
    Table 159. Europe Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
    Table 160. Europe Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
    Table 161. Europe Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
    Table 162. Europe Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
    Table 163. Europe Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
    Table 164. Europe Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
    Table 165. Latin America Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
    Table 166. Latin America Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
    Table 167. Latin America Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
    Table 168. Latin America Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
    Table 169. Latin America Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
    Table 170. Latin America Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
    Table 171. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
    Table 172. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
    Table 173. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
    Table 174. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
    Table 175. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
    Table 176. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
    Table 177. Pharmaceutical Intermediates Key Raw Materials, Industry Status and Trend
    Table 178. Pharmaceutical Intermediates Key Raw Materials and Upstream Suppliers
    Table 179. Pharmaceutical Intermediates Clients Status and Trend
    Table 180. Pharmaceutical Intermediates Typical Clients
    Table 181. Pharmaceutical Intermediates Distributors
    Table 182. Pharmaceutical Intermediates Market Trends
    Table 183. Pharmaceutical Intermediates Market Drivers
    Table 184. Pharmaceutical Intermediates Market Challenges
    Table 185. Pharmaceutical Intermediates Market Restraints
    Table 186. Research Programs/Design for This Report
    Table 187. Key Data Information from Secondary Sources
    Table 188. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pharmaceutical Intermediates Product Picture
    Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2021 & 2028
    Figure 3. GMP Product Picture
    Figure 4. Non-GMP Product Picture
    Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2021 & 2028
    Figure 6. Antibiotics Examples
    Figure 7. Antipyretic Analgesics Examples
    Figure 8. Vitamins Examples
    Figure 9. Others Examples
    Figure 10. Pharmaceutical Intermediates Report Years Considered
    Figure 11. Global Pharmaceutical Intermediates Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Pharmaceutical Intermediates Market Size 2017-2028 (US$ Million)
    Figure 13. Global Pharmaceutical Intermediates Sales 2017-2028 (K MT)
    Figure 14. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2022 Versus 2028
    Figure 15. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2017-2028)
    Figure 16. Global Pharmaceutical Intermediates Revenue Market Share by Region (2017-2028)
    Figure 17. Global Pharmaceutical Intermediates Sales Share by Manufacturer in 2021
    Figure 18. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Pharmaceutical Intermediates Sales Market Share Forecast by Type (2017-2028)
    Figure 20. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Type (2017-2028)
    Figure 21. Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2017-2022) & (USD/MT)
    Figure 22. Global Pharmaceutical Intermediates Sales Market Share Forecast by Application (2017-2028)
    Figure 23. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Application (2017-2028)
    Figure 24. Pharmaceutical Intermediates Average Selling Price (ASP) by Application (2017-2022) & (USD/MT)
    Figure 25. North America Pharmaceutical Intermediates Revenue 2017-2028 (US$ Million)
    Figure 26. North America Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
    Figure 27. North America Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
    Figure 28. Asia-Pacific Pharmaceutical Intermediates Revenue 2017-2028 (US$ Million)
    Figure 29. Asia-Pacific Pharmaceutical Intermediates Sales Market Share by Region (2017-2028)
    Figure 30. Asia-Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2017-2028)
    Figure 31. Asia-Pacific Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
    Figure 32. Asia-Pacific Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
    Figure 33. Europe Pharmaceutical Intermediates Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 34. Europe Pharmaceutical Intermediates Sales Market Share by Country (2017-2028)
    Figure 35. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2017-2028)
    Figure 36. Europe Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
    Figure 37. Europe Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
    Figure 38. Latin America Pharmaceutical Intermediates Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 39. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2017-2028)
    Figure 40. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2017-2022)
    Figure 41. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
    Figure 42. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
    Figure 43. Middle East and Africa Pharmaceutical Intermediates Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 44. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2017-2028)
    Figure 45. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2017-2028)
    Figure 46. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
    Figure 47. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
    Figure 48. Pharmaceutical Intermediates Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Pharmaceutical Intermediates Raw Materials by Region in 2021
    Figure 50. Pharmaceutical Intermediates Distribution Channels
    Figure 51. Global Pharmaceutical Intermediates Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 52. Global Pharmaceutical Intermediates Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Risperidone Market Insights and Forecast to 2028
Global and United States Risperidone Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-34S6889
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Erythropoietin ELISA Test Kit Market Research Report 2022
Global and United States Erythropoietin ELISA Test Kit Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-32I12133
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Synthetic Bioinks Market Research Report 2022
Global and United States Synthetic Bioinks Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-15I12294
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Fluorinated Pharmaceutical Intermediates Market Research Report 2022
Global Fluorinated Pharmaceutical Intermediates Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-18A12300
Thu Nov 03 00:00:00 UTC 2022

Add to Cart